Difficulty: Medium
Average Score: 94%
Practice
With regard to clinical trials of new drugs, which of the following is most correct?
Correct answer
A
Rationale
Phase I involves the study of a small number of normal volunteers by highly trained clinical pharmacologists (A), assessing safety, pharmacokinetics, and tolerability (e.g., 20-100 subjects) in controlled settings. Phase II (B) tests efficacy in patients (100-300), not thousands. Phase III (C) compares efficacy and safety in larger populations (300-3000), not inducing toxicity for therapeutic index. Option D is irrelevant. Phase II with controls (original E) is true but less defining than A. Phase I's focus on healthy subjects establishes safe dosing, critical for advancing drug development, balancing risk and scientific rigor.